内视镜逆行性造影（ERCP）全球市场规模、份额、趋势与成长分析报告（2026-2034年）

预计内视镜逆行性造影(ERCP) 市场将从 2025 年的 29.9 亿美元成长到 2034 年的 63.3 亿美元，2026 年至 2034 年的复合年增长率为 8.69%。

随着胃肠道诊断和治疗性介入需求的不断增长，内视镜逆行性造影（ERCP）市场也蓬勃发展。内视镜、支架和导管导引线技术的进步提高了ERCP手术的准确性、安全性和有效性。胆管和胰臟疾病发生率的上升，以及微创技术的进步，正推动ERCP在全球医院和专科诊所的广泛应用。

未来的成长将由新一代成像系统、机器人技术和人工智慧驱动的诊断工具所主导。包括高清内视镜和即时分析在内的视觉化技术的进步，正在提高检出率和手术成功率。一次性ERCP器械因其能够解决感染控制问题并提高操作效率，正变得越来越重要。此外，配备虚拟实境（VR）和模拟工具的培训平台正在加速医疗专业人员的技能发展，并确保先进手术技术的广泛应用。

医疗基础设施投资的增加和专业医疗服务的全球化正在提振市场前景。设备製造商与研究机构之间的合作开发推动了创新进程，而以病人安全为中心的法规则确保了品质的持续改进。随着技术创新重新定义微创介入治疗，ERCP市场预计将作为先进胃肠道医疗保健的重要组成部分继续扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球内视镜逆行性胰造影（ERCP）市场：依产品分类

• 市场分析、洞察与预测
• 内视镜
• 内视镜治疗设备
• 视觉化系统
• 能量装置
• 其他的

第五章 全球内视镜逆行性胰造影（ERCP）市场：依手术类型划分

• 市场分析、洞察与预测
• 胆道括约肌切开术
• 胆道支架置入术
• 胆管扩张
• 胰管括约肌切开术
• 胰管支架置入术
• 胰管扩张

第六章 全球内视镜逆行性胰造影（ERCP）市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 门诊部

第七章 全球内视镜逆行性胰造影（ERCP）市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Olympus Corporation
  • Conmed Corporation
  • Boston Scientific Corporation
  • Medtronic PLC
  • Telemed System Inc
  • Ambu Inc
  • Fujifilm Holdings Corporation
  • Hobbs Medical Inc
  • Cook Group
  • Streis PLC
  • HOYA Group
  • Karl Storz SE & Co. KG

The Endoscopic Retrograde Cholangiopancreatography Market size is expected to reach USD 6.33 Billion in 2034 from USD 2.99 Billion (2025) growing at a CAGR of 8.69% during 2026-2034.

The market for endoscopic retrograde cholangiopancreatography (ERCP) is advancing as gastrointestinal diagnostics and therapeutic interventions grow in demand. Technological innovations in endoscopes, stents, and guidewires are enhancing the precision, safety, and efficacy of ERCP procedures. The rising incidence of bile duct and pancreatic disorders, combined with advancements in minimally invasive techniques, is driving adoption in hospitals and specialty clinics worldwide.

Future growth will be shaped by next-generation imaging systems, robotics, and AI-powered diagnostic tools. Enhanced visualization through high-definition endoscopes and real-time analytics is improving detection rates and procedural success. Disposable ERCP devices are gaining importance, addressing infection control concerns and streamlining operational efficiency. Furthermore, training platforms with virtual reality and simulation tools are enhancing skill development among practitioners, ensuring wider adoption of advanced procedures.

The market outlook is reinforced by increasing investments in healthcare infrastructure and the globalization of specialized medical services. Collaborative partnerships between device manufacturers and research institutions are driving innovation pipelines, while regulatory emphasis on patient safety ensures continuous quality improvements. With technology redefining minimally invasive interventions, the ERCP market is positioned to expand as a critical component of advanced gastrointestinal care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Endoscopes
• Endotherapy Devices
• Visualization Systems
• Energy Devices
• Others

By Procedure

• Biliary Sphincterotomy
• Biliary Stenting
• Biliary Dilatation
• Pancreatic Sphincterotomy
• Pancreatic Duct Stenting
• Pancreatic Duct Dilation

By End Use

• Hospitals
• Outpatient Facilities

COMPANIES PROFILED

• Olympus Corporation, Conmed Corporation, Boston Scientific Corporation, Medtronic PLC, Telemed System Inc, Ambu Inc, Fujifilm Holdings Corporation, Hobbs Medical Inc, Cook Group, Streis PLC, HOYA Group, Karl Storz SE amp Co KG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Endoscopes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Endotherapy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Visualization Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Energy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure
• 5.2. Biliary Sphincterotomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biliary Stenting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Biliary Dilatation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Pancreatic Sphincterotomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Pancreatic Duct Stenting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Pancreatic Duct Dilation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Outpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Procedure
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Procedure
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Procedure
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Procedure
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Procedure
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Olympus Corporation
  • 9.2.2 Conmed Corporation
  • 9.2.3 Boston Scientific Corporation
  • 9.2.4 Medtronic PLC
  • 9.2.5 Telemed System Inc
  • 9.2.6 Ambu Inc
  • 9.2.7 Fujifilm Holdings Corporation
  • 9.2.8 Hobbs Medical Inc
  • 9.2.9 Cook Group
  • 9.2.10 Streis PLC
  • 9.2.11 HOYA Group
  • 9.2.12 Karl Storz SE & Co. KG